Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Antibody biomarkers in CNS demyelinating diseases - a long and winding road.
B cells and progressive multifocal leukoencephalopathy: search for the missing link.
Multiple sclerosis: A clinically useful genetic variant in multiple sclerosis?
Assessing PML risk under immunotherapy: if all you have is a hammer, everything looks like a nail.
Immunomodulatory characteristics of mesenchymal stem cells and their role in the treatment of Multiple Sclerosis.
Anti-CCP Antibody Levels Are Not Associated with MS: Results from a Case-Control Study.
Celastrol Ameliorates EAE Induction by Suppressing Pathogenic T Cell Responses in the Peripheral and Central Nervous Systems.
Consistent reduction in the annualized rate of brain volume loss across phase 3 core and extension trials of fingolimod in relapsing multiple sclerosis.
The impact of isolated lesions on white-matter fiber tracts in multiple sclerosis patients.
Multiparameter Flow Cytometric Assays to Quantify Effector and Regulatory T-Cell Function in Multiple Sclerosis.
Progress and Roadblocks Along the Pathway to Multiple Sclerosis Treatment.
Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis.
Tai Chi Chuan in Medicine and Health Promotion.
Use of herbal remedies by multiple sclerosis patients: a nation-wide survey in Italy.
Plasma Exchange and Immunoadsorption in Pediatric Inflammatory Optic Neuropathy Resistant to Corticosteroid Therapy: Four French Cases.
Causes of death among persons with multiple sclerosis.
Use of altered informed consent in pragmatic clinical research.
Are PrP(C)s involved in some human myelin diseases? Relating experimental studies to human pathology.
Curbing Inflammation in Multiple Sclerosis and Endometriosis: Should Mast Cells Be Targeted?
Minimal clinically important difference for change in comfortable gait speed of adults with pathology: a systematic review.
Anti-aquaporin 4 antibody-positive acute disseminated encephalomyelitis.
Medical management of fecal incontinence in challenging populations: a review.
Markers of JC virus infection in patients with multiple sclerosis under natalizumab therapy.
Iron-based superparamagnetic nanoparticle contrast agents for MRI of infection and inflammation.
[Multiple sclerosis: socioeconomic effects and impact on quality of life].
Pages
« first
‹ previous
…
630
631
632
633
634
635
636
637
638
…
next ›
last »